Skip to main content
Premium Trial:

Request an Annual Quote

Color Raises $167M in Series D Financing Round

NEW YORK — Color said on Monday that it has closed a $167 million Series D round of financing.

The round was led by General Catalyst and funds and accounts advised by T Rowe Price Associates, with participation from Viking Global Investors. Color said that it has raised $278 million to date, giving it a $1.5 billion valuation.

A year ago, the company said it raised $75 million in a financing round to scale its infrastructure.

Color said that it will use the new funding to continue building its technology-based public health infrastructure for governments, employers, and other institutions serving large populations.

"Color is building the technology framework that enables millions of people to access … essential [healthcare] services outside of the traditional health systems," Color Chief Commercial Officer Caroline Savello said in a statement.

While Color is known for providing hereditary risk testing for cancer and cardiovascular conditions, the San Francisco-based company has expanded into SARS-CoV-2 testing and recently opened a lab dedicated to testing for the virus. In May, Color received Emergency Use Authorization from the US Food and Drug Administration for a loop-mediated isothermal amplification-based SARS-CoV-2 test.

Color said that it is also rolling out vaccine delivery systems to state and local governments, employers, and higher education institutes.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.